The HELlenic Thoracic Society Initiative for CΟPD and CVD

Hellenic Thoracic Society900 enrolled

Overview

COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.

Study Type

OBSERVATIONAL

Enrollment

900

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Cardiovascular Diseases (CVD)

Eligibility

Sex: ALLMin age: 35 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion criteria Patients should cumulatively meet the following three (3) criteria to be enrolled in the study: 1. To have been diagnosed with chronic obstructive pulmonary disease and at least one cardiovascular comorbidity (heart failure, atherosclerotic cardiovascular disease, atrial Fibrillation, severe valvular disease) 2. Adults aged \>35 years at the time of inclusion in the study, 3. With signed informed consent for their participation in the study. Exclusion criteria Patients with the below limitations are not eligible to participate in the study Patients: 1. Without at least one cardiovascular comorbidity, 2. With history of lung cancer 3. With any other active malignancy and undergoing treatment (chemotherapy/radiotherapy/immunotherapy) 4. With any thoracic or abdominal surgery planned during study follow-up period 5. With participation in any COPD-related interventional study at study entry or during study duration. 6. Without signed informed consent for their participation in the study.

Locations (2)

Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital

Alexandroupoli, Greece

RECRUITING

5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, Greece

Athens, Greece

RECRUITING

Outcomes

Primary Outcomes

Number of moderate or severe COPD exacerbations

Moderate COPD exacerbation: typically requires outpatient management, it is characterized by an increased need for medication, specifically the use of systemic corticosteroids and/or antibiotics. Severe COPD exacerbation: indicated by an acute worsening of symptoms that requires hospitalization.

Time frame: Up to 24 months

Number of cardiovascular complications/outcomes

Cardiovascular complications/outcomes, including a) acute coronary syndrome, b) ischemic stroke, c) pulmonary embolism, d) reperfusion, e) worsening of heart failure that required a visit to the Emergency Department (ED) or hospitalization (short or longer), f) other hospitalization in a cardiology clinic (causes other than acute coronary syndrome, reperfusion, and heart failure), g) death related to cardiovascular disease.

Time frame: Up to 24 months

Secondary Outcomes

Unscheduled hospital admission due to COPD

Time frame: Up to 24 months

Unscheduled hospital admission due to any other reason

Time frame: Up to 24 months

The HELlenic Thoracic Society Initiative for CΟPD and CVD

Overview

Conditions

Eligibility

Locations (2)

Outcomes

Primary Outcomes

Secondary Outcomes

Central Contacts